| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |